Blog / Chiropractic

How to Calculate What a New Chiropractic Patient Is Worth

Build the number from your own data before an agency quotes you a cost per lead. The formula, the inputs, and where clinics get it wrong.

How to Calculate What a New Chiropractic Patient Is Worth

A new chiropractic patient is worth what you actually collect across every visit they attend, plus the collected value of the patients they refer. Build it from your own practice-management data — collections, not billed charges, and attended visits, not scheduled ones. That number is what sets the most you can defensibly pay to acquire one.

Most clinics never run this math. The ones that do get it wrong in the same few places, and the errors all run the same direction: they make the patient look more valuable than they are, which makes an expensive channel look affordable. The calculation is not difficult. It requires reports you already have, and honesty about which ones flatter you.

Step one: collections per attended visit

Pick a clean period. Twelve months is usually right, because it absorbs deductible resets and seasonal swings. Take total collections for that period — not production, not billed charges. The money that arrived and stayed. Subtract refunds and any prepaid plan balances you returned, then divide by the visits patients actually attended.

That is collected revenue per attended visit. It is almost always lower than the fee on your schedule, and the gap is the first thing this exercise teaches you.

Step two: how many visits a patient actually attends

This is where practices substitute the care-plan template for reality. A recommended plan is a proposal. Attendance is an outcome.

Use a cohort, not an average

Take every patient whose first visit fell in a single month twelve to eighteen months ago. Now count every visit each of them has attended since. Total those visits, divide by the number of patients in the cohort. That is your average attended visits per new patient, and it includes the ones who vanished after visit three, which is the point.

A six-month cohort understates value for patients still under active care. A three-year cohort is too stale to describe how you practice now. Twelve to eighteen months is the usable compromise.

Multiply step one by step two. That is gross patient value in collections.

Cash-pay and insurance are not the same business

Run these numbers separately by payer type. Blending them produces a figure that describes no patient you actually treat.

For insurance patients the relevant number is the allowed amount, not your fee, and only the collectible portion of it. Visit caps end care plans regardless of clinical need. Deductibles push collections into the back half of the year. Denials, write-offs and payment lag all sit between the visit and the cash. Calculate any major payer on its own.

For cash-pay patients the money often arrives up front as a prepaid plan. That is a genuine advantage, because the payback is immediate. It is also the easiest place to overstate value: unused visits may be refundable, and collecting for a full plan does not mean the full plan was delivered. If your plans carry a refund policy, patient value is what you kept, not what you charged.

Two clinics with identical visit counts can therefore have patient values that are not remotely comparable, and neither can use the other’s marketing budget.

Show rate is the multiplier most clinics ignore

Marketing does not buy patients. It buys booked appointments. The difference is your new-patient show rate, and it quietly changes every number downstream.

A clinic that reports cost per booked appointment and calls it cost per new patient understates its true acquisition cost by exactly the share of bookings that never walk in. Cheap leads with a weak show rate routinely cost more per patient than expensive leads with a tight confirmation process.

It applies twice. Once at the front — booked to arrived. And again throughout the care plan, where every missed visit is a visit never collected on, which pulls down step two. Pull both ratios from your practice-management system. They are the cheapest thing on this list to improve, and they move patient value and acquisition cost at the same time.

What a referral from an existing patient is worth

Take the same cohort. Count how many new patients named a cohort member as their referral source. Divide by the cohort size. That is referrals per patient.

Multiply that by gross patient value and add it back. Count one generation only. Referrals of referrals compound to an impressive and completely unfinanceable number.

This only works if your referral-source field is filled in consistently, and in most clinics it is not. If the data is unreliable, leave referral value out rather than estimating it. An acquisition budget built on a guessed multiplier is how clinics overspend for a year before noticing.

Working backwards to a target cost per new patient

Patient value is not a budget. Margin is.

  1. Subtract the variable cost of delivering that care. Associate compensation, supplies, billing fees, merchant fees, imaging. Rent and front-desk salary do not vary with one more patient, so most clinics leave them out — but be consistent.
  2. Decide what share of that margin to spend on acquisition. A business decision, not a formula: how much growth you want, against how much profit you will trade for it.
  3. Apply a payback window. Only count value arriving inside a period you can finance. Prepaid plans allow a longer horizon than insurance remittances do.

The result is your target cost per new patient — where “patient” means someone who arrived and began care.

Then convert it to a target cost per lead

Multiply your target cost per new patient by the full conversion chain: lead to booked, booked to arrived, arrived to started care. If one lead in four survives all three steps, your target cost per lead is a quarter of your target cost per patient. Every improvement in those rates raises what you can afford to bid.

A hypothetical worked example

The following numbers are invented and deliberately round. They are not benchmarks and they are not typical of anything. They exist only to show the arithmetic.

Suppose a hypothetical clinic collects $60 per attended visit, and its twelve-month cohort attended an average of 20 visits per new patient. Gross patient value is $1,200. Suppose referrals add 0.2 patients each, worth another $240, for $1,440 total. Suppose variable delivery cost is 40 percent, leaving $864 of margin. If that clinic chooses to spend a quarter of margin on acquisition, its target cost per new patient is $216. If one lead in four becomes a patient, its target cost per lead is $54.

Worsen the show rate in that chain so only one lead in six becomes a patient, and the lead target falls to $36. That single ratio decides whether a channel is viable.

The four miscounts that break this

Run it in this order

  1. Pull twelve months of collections, net of refunds and returned plan balances, and attended visits for the same period. Divide.
  2. Build a new-patient cohort from a single month, twelve to eighteen months back.
  3. Count every visit that cohort has attended since. Divide by cohort size.
  4. Split the whole thing by payer type — at minimum cash versus insurance.
  5. Pull booked-to-arrived and scheduled-to-attended rates.
  6. Add referral value only if your referral-source data is genuinely reliable.
  7. Subtract variable delivery cost, choose a share of margin, set your targets.

When this does not apply

A clinic under two years old has no cohort old enough to trust. It should treat any figure it produces as provisional and recalculate quarterly. A clinic that has recently changed its care model, fee schedule or payer mix has invalidated its own history, and has to rebuild the number from the period since the change.

If the referral-source field has been blank for years, fix intake now and calculate referral value in twelve months. Do not estimate it and spend against the estimate.

Related

Want this handled properly?

See how we’d approach it →